Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 925,250 | 634,368 | 519,757 | 534,862 | 570,614 |
| Marketable Securities | 178,138 | 247,757 | 121,629 | 138,901 | 231,208 |
| Receivables | 166,133 | 73,750 | 75,688 | 101,563 | 86,168 |
| Inventories | 26,206 | 25,051 | 16,354 | 13,872 | 8,536 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 86,445 |
| Other current assets | 165,959 | 0 | 0 | 0 | 0 |
| TOTAL | $1,496,576 | $1,011,434 | $759,730 | $821,229 | $1,005,851 |
| Non-Current Assets | |||||
| PPE Net | 514,182 | 485,275 | 443,656 | 403,091 | 289,755 |
| Investments And Advances | 187,782 | 314,364 | 393,904 | 321,015 | 296,335 |
| Intangibles | 512,001 | 500,735 | 524,958 | 435,215 | 341,274 |
| Other Non-Current Assets | 154,846 | 221,746 | 187,858 | 152,743 | 50,797 |
| TOTAL | $1,368,811 | $1,522,120 | $1,550,376 | $1,312,064 | $978,161 |
| Total Assets | $2,865,387 | $2,533,554 | $2,310,106 | $2,133,293 | $1,984,012 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,922 | 14,373 | 17,544 | 20,710 | 15,898 |
| Accrued Expenses | 243,128 | 207,034 | 169,055 | 169,307 | 158,376 |
| Other current liabilities | 17,468 | N/A | N/A | N/A | N/A |
| TOTAL | $285,198 | $245,773 | $213,083 | $209,681 | $189,370 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 23,150 | 24,180 | 18,910 | 12,496 |
| Other Non-Current Liabilities | 209,127 | 106,889 | 82,380 | 75,174 | 41,098 |
| TOTAL | $209,686 | $143,939 | $118,288 | $107,605 | $62,994 |
| Total Liabilities | $494,884 | $389,712 | $331,371 | $317,286 | $252,364 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,263 | 102,289 | 101,484 | 100,851 | 102,287 |
| Common Shares | 102 | 101 | 101 | 102 | 103 |
| Retained earnings | 2,313,539 | 2,083,063 | 1,938,320 | 1,800,857 | 1,660,485 |
| Other shareholders' equity | -9,265 | -653 | -1,718 | -2,523 | 24,645 |
| TOTAL | $2,370,503 | $2,143,842 | $1,978,735 | $1,816,007 | $1,731,648 |
| Total Liabilities And Equity | $2,865,387 | $2,533,554 | $2,310,106 | $2,133,293 | $1,984,012 |